Series: Essential Guide to Prescription Drugs | Publication Date: November 30, 2004
The Essential Guide to Prescription Drugs has been used for more than twenty-five years by informed consumers interested in obtaining full information about the medicines they take. Revised annually to help readers stay abreast of continual innovations in drug therapy, each edition continues to provide the detailed profiles of prescription drug information that families have come to expect and rely on. Each drug profile offers a great depth of information, which includes crucial facts about medical conditions and drug combinations that often require dosing adjustments. For example, if you or a family member suffer a liver or kidney ailment you'll learn how medication dose or frequency may need to be modified to help avoid dangerous and unnecessary toxic drug reactions.
Each of the more than 300 drug profiles opens with an easy-to-read informational box outlining the benefits and risks of the drug, followed by information on available dosage forms and strengths, examples of what the drug treats when used alone or as part of a combination product, the advisability of use during pregnancy or when nursing, adverse effects and common side effects, and much more.
Ongoing research helps expand and shape our understanding of how diseases happen and often leads to the development of revolutionary new medicines. In "The Leading Edge," Dr. Rybacki makes readers aware of promising new medications awaiting FDA approval, and in "True Breakthroughs," he describes novel drugs recently approved by the FDA and also details previously undiscovered new uses for older medicines. A unique feature called "Typical Treatment Goals and Measurements" explains what your doctor is usually trying to accomplish with medicines to help you and your family stay at the center of care.
While no book can be substituted for the professional judgment of a doctor, The Essential Guide to Prescription Drugs does offer the information you need to take today's complex and potent drugs intelligently, safely, and effectively.
--This text refers to an out of print or unavailable edition of this title.
James J. Rybacki, Pharm.D., is president of The Clearwater Group, an international therapeutic, professional, education, research, and management concern; a clinical assistant professor at the University of Maryland; and a spokesperson for the American Heart Association's "Get with the Guidelines" program. He lives in Maryland.
--This text refers to an out of print or unavailable edition of this title.
About the Author JAMES J. RYBACKI, Pharm.D., was born in Oneonta, New York. He received his prepharmacy education at Creighton University and his Doctor of Pharmacy degree from the University of Nebraska Medical Center, College of Pharmacy, in Omaha. Dr. Rybacki has more than three decades of hospital and clinical experience that include early efforts in gas-liquid chromatography research characterizing human drug metabolites, and data collection for the College of American Pathologists to establish normal values for laboratory studies.
He is the editor of www.EssentialGuideToPrescriptionDrugs.com and is a member of the clinical faculty at the University of Maryland School of Pharmacy and has provided clinical rounding and hospital experience for Pharm.D. and bachelor students. He presently teaches a Drug Information rotation for Pharm.D. students at The Clearwater Group. He is board certified in pain management at the Diplomat level by the American Academy of Pain Management, and provides ongoing clinical pain management and medicine information nationwide.
He is a guest lecturer and researcher at the Department of Family Medicine at the Georgetown University School of Medicine. He is a member of The National Council of Hospice Professionals, the American Society for Preventive Cardiology, The National Lipid Association and sits on the National Advisory Council of the Mended Hearts International. Dr. Rybacki was actively involved in the post marketing monitoring of medicines via The Drug Surveillance Network, a nationwide association of clinical pharmacists, and he is an approved External New Drug Application reviewer for the Canadian Drug Ministry. He lives in Maryland.
Dr. Rybacki's efforts in drug information and clinical pharmacy include many years of active practice, including infectious disease, pharmacokinetic, nutrition support, pain management, and pharmacological consultations. Through an Occupational Health Unit, he has offered independent pain management and pharmacological consultations nationwide. He has also advised the World Health Organization's Expert Committee regarding revisions as well as the selection of drugs to be listed in The Use of Essential Drugs and is an assistant editor for the Drugdex drug information system. His past role as a Vice President Clinical Services bought him added expertise in overseeing occupational health, physical medicines, laboratory services, imaging, cardiology, respiratory therapy, cancer programs, and continuing medical education. He served as conference coordinator for the first and second annual Dorchester General Hospital Pain conferences and as seminar coordinator for the eastern shore of Maryland for the "Take Control" physician and public pain education programs with Johns Hopkins.
Dr. Rybacki is now president of The Medicine Information Institute--headquartered in Maryland. He provides drug information support and clinical pharmacy services to physician groups, consumers, and employers; holds seminars and continuing education meetings on diabetes, cardiovascular disease, infectious disease, adherence, osteoporosis, pain management, women's health, and therapeutics; provides information support to insurance companies and HMOs; provides on-site hospital consulting on JCAHCO pain standards, optimizing use of medicines and other programs, produces educational tapes and television programming on medicines; designs clinical programs; conducts independent pharmacological evaluations and has most recently been the Health System Director of Pharmacy at the University of Texas Southwestern Medical Center.
He served on the Patient Education and Professional Education Committees of the American Heart Association on a national level, was the first Pharm.D. Committee member of the American Heart Association Pharmaceutical Roundtable and is actively designing research involving how, why, and when to enhance the way people take their medicines and decrease risk factors for cardiovascular disease. He is a strong advocate of a multilevel/interdisciplinary approach to help patients get the most from their medicines and is designing projects to involve pharmacists/physicians/PAs/nurses/nurse practitioners/cardiac rehab programs at the practice site itself in helping patients and families understand risk factors, proven medicines and how to get the best results over time. Medicines and Your Family, National Treatment Guidelines was the first publication resulting from this novel focus and the second edition, Heart Attack transition was guest edited by Roger S. Blumenthal, MD and is now available on Amazon.
He was selected for full membership in the American College of Clinical Pharmacy, is a Certified Clinical Densitometrist (CCD) through the Society for Clinical Densitometry, served a two-year term appointed by the governor of Maryland on a state-wide Osteoporosis Task Force in Maryland (see www.strongerbones.org). He is a lifetime member of Who's Who in Global Business. Dr. Rybacki is director of clinical research, therapeutics, and outcomes at the Medicine Information Institute--an interdisciplinary consulting and education group. Dr. Rybacki has been a frequent guest on Comcast's Family Talk live television program as well as their Real Life TV. He is now the writer and host of a patient education series called Medicines and Your Family with Dr. Jim Rybacki. You may have also heard him as the voice and writer of the Bayer Aspirin Pharmacist Report (a short-segment program on preventing a first heart attack). Catch Dr. Jim on TV, the Web, and on the radio (www.EssentialGuideToPrescriptionDrugs.com!
An active national speaker, Dr. Rybacki gave the keynote address at the 2004 Mended Hearts Leadership Conference, The MCV Update for Clinicians talking about Women and cardiology Disparities,spoke at the Simmons Cnacer Center in Dallas Texas on adherence in cancer treatments,was the Mended Hearts spokesperson for the AACE State of Diabetes Complications in America campaign and spoke at the University of Maryland Department of Imaging Spring Symposium on Safe Use of Sterile Contrast Agents. He was a member of the Bristol-Myers Squibb Distinguished faculty in HIV faculty from 1994 to 2003, lectured across the country and now speaks on heart disease. He has jointly authored several articles in professional journals on use of medicines in infectious diseases, critical care, therapeutics, and cost containment and adherence. The Essential Guide to Prescription Drugs, first published in 1977, was co-authored by Dr. Rybacki since 1994, before he assumed full authorship in 1996. Dr. Rybacki leveraged his expertise on medicines to The Medicine Man, a nationwide live radio show, which was developed, written, produced, and hosted by Dr. Rybacki in 1995. He is the original writer and host of the American Pharmaceutical Association's The Pharmacist Minute radio program, and is the writer, producer, and host of Medicines and Your Family with Dr. Jim Rybacki. He is a frequent guest on The Kojo Nnamdi Show on WAMU (NPR), AARP Prime Time and others.
Dr. Rybacki created a new book supported by an unrestricted educational grant from the Mended Hearts via Bristol-Myers Squibb/ Sanofi Pharmaceuticals Partnership. The book is called Medicines and Your Family, National Treatment Guidelines and has had more than 100,000 copies of the first edition given to heart patients and their families by The Mended Hearts, Inc. (www.mendedhearts.org). The first update was released in 2011 and benefits from the thoughts and input from Dr. Blumenthal at Johns Hopkins. Dr. Rybacki thinks that the best colleague any doctor can have is a more fully informed patient. Dr. Rybacki brings late-breaking information to people via popular sites on the World Wide Web at www.EssentialGuideToPrescriptionDrugs.com.
This review is from: The Essential Guide to Prescription Drugs 2005 : Everything You Need to Know for Safe Drug Use (The Essential Guide to Prescription Drugs) (Paperback)
I have been using and buying this book since it was 1st published. I love it!
I'm an RN. I train non-professionals and family members on medications.
This is an invaluable tool!
The fact that it is in English (not technical words), explains medical jargon,uses,side effects, etc and catagories of real life situations, many people can relate.
I use it frequently.
Thank you for demystifing medications.
Mecrn
Help other customers find the most helpful reviews
First Sentence:
When you're sick and finally make that decision to see your doctor, it's probably one of the worst times for you to think about the medicines you take now or even that new prescription. Read the first pageKey Phrases - Statistically Improbable Phrases (SIPs): (learn more)
single drug product, unavoidable drug actions, refrain from nursing, periodic physician evaluation, more frequent blood levels, infrequent reactions, monograph indication, dofetilide toxicity, not double doses, people with damaged immune systems, liver damage with jaundice, treating pain use, missed dose right, liver compromise, skip the missed dose, heart disease risk independently, other aspirin substitutes, patients with compromised kidneys, cause excessive lowering, kidney compromise, surgery with general anesthesia, additive potassium loss, rescue inhaler use, way ginseng works, inform your physician
Key Phrases - Capitalized Phrases (CAPs): (learn more)
Controlled Drug, Possible Risks, Natural Diseases, Usual Duration of Use, Aviation Note, Conditions Requiring Dosing Adjustments Liver Function, Risk Categories, Observe the Following Foods, Mild Adverse Effects Allergic, Aviation Medical Examiner, Serious Adverse Effects Allergic, Disorders That May Be Activated, Usual Adult Dosage Ranges, Possible Advantages of This Drug, Marijuana Smoking, Recommended Dosage Ranges, Combination Drug Product, Possible Delayed Adverse Effects, Laboratory Tests Complete, Occurrence of Unrelated Illness, Laboratory Tests Blood, Disorders Liver, Other Names, Special Storage Instructions, African Americans
New! Books on Related Topics |
Concordance
|
Text StatsBrowse Sample Pages: Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
